Taurohyodeoxycholic acid
CAS : 2958-04-5
Ref. 3D-FT28007
| 2mg | Arrêté | ||
| 5mg | Arrêté | ||
| 10mg | Arrêté | ||
| 25mg | Arrêté | ||
| 50mg | Arrêté |
Informations sur le produit
Nom :
Taurohyodeoxycholic acid
Synonymes :
- 2-[[(3a,5b,6a)-3,6-Dihydroxy-24-oxocholan-24-yl]amino]ethanesulfonic acidN-(3a,6a-Dihydroxy-5b-cholan-24-oyl)taurineTaurine hyodeo xycholate
Description :
Taurohyodeoxycholic acid (THDCA) is a bile acid that is used for the treatment of chronic inflammatory bowel disease. It is believed to work by reducing the production of pro-inflammatory cytokines, thereby reducing inflammation. THDCA has also been shown to inhibit the enzyme polymerase chain reaction, which may be useful in preventing infections caused by bacteria or viruses. It has been shown to have a positive effect on energy metabolism and cell lysis, as well as an antibody response and bowel disease. THDCA has been shown to have beneficial effects on hepatic steatosis and locomotor activity in experimental models.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
499.7 g/mol
Formule :
C26H45NO6S
Degré de pureté :
Min. 95%
Couleur/Forme :
White To Off-White Solid
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
